JPRN-UMIN000011190
Completed
Phase 2
Problem-solving therapy for breast cancer patients undergoing chemotherapy on an outpatient basis - Problem-solving therapy for breast cancer patients
Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University0 sites100 target enrollmentSeptember 1, 2013
ConditionsBreast cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Breast cancer
- Sponsor
- Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) History of other malignancy except for curatively treated carcinoma 2\) Severe cognitive dysfunction 3\) Severe psychiatric disorder
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Cyclophosphamide chemotherapy for breast cancers harboring TP53 gene mutationsocally advanced breast cancer and metastatic breast cancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-003459-31-NOHelse Bergen, Haukeland University Hospital190
Completed
Phase 3
Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up. A Dutch randomized controlled multicentre trial.breast cancersentinel lymph node metastasessentinel lymph nodes1000629110006295NL-OMON54499Medisch Universitair Ziekenhuis Maastricht1,730
Recruiting
Not Applicable
Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up (BOOG 2013-08).breast neoplasmsbreast cancersentinel lymph node biopsybreast conserving therapy.NL-OMON28389KWF, CZ, ZonMw1,644
Not yet recruiting
Not Applicable
A study on the impact of pharmaceutical care on breast cancer patientsHealth Condition 1: C50- Malignant neoplasm of breastCTRI/2020/07/026688Self funded
Recruiting
Not Applicable
Treatment of patients with breast cancer or gastrointestinal cancer and chemotherapy-induced polyneuropathia with whole body vibration (Galileo technology)Chemotherapy induced polyneuropathyG62Other polyneuropathiesDRKS00006181Klinik für Tumorbiologie50